Report Description

Next Generation Sequencing Kits Laparoscopy market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising advancements NGS platform such as using the iSeq 100 system and Ion Gene Studio S5 in the technology for better testing across the globe. Similarly, the growing improvement of regulatory and reimbursement scenarios for NGS-based diagnostics tests will further drive the growth of the market over the years. Additionally, the growing prevalence of cancer and increasing applications of next-generation sequencing in cancer and other infectious diseases research is expected to create significant growth during the forecasted period. Moreover, the growing development of portable sequencing technologies along with growing partnerships & collaborations for technological advancements in NGS with major key players and research institutes is expected to drive the growth of the market during the forecast period.

Growing Advancements in NGS
Growing demand for DNA testing for the diagnosis of some rare genetic diseases such as cystic fibrosis and sickle cell diseases has significantly increased over the years. Additionally, the growing demand for advanced technology which can provide faster results at less cost is expected to drive the growth of global next generation sequencing kits market during the forecast period.

For instance, in January 2022, a new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators used to diagnose rare genetic diseases in an average of eight hours. Genome sequencing helps scientists to find a patient’s complete DNA makeup which contains information about everything from eye color to inherited diseases and it is vital for diagnosing patients with diseases rooted in their DNA. Also, the growing genome mapping program linked to different types of diseases and understanding inherited disorders and their treatment will further drive the growth of the market during the forecast period. Public, private, and non-profit interests have also invested largely in the technology to treat novel diseases and improve diagnostics and healthcare. Increased availability of funding supported by the next-generation sequencing market will further enhance the demand for the NGS kits market during the forecast period.

 


Download Free Sample Report

Growing Demand for Early Detection of Chronic Diseases
For the successful treatment of cancer and other infectious diseases in the early stage, NGS technology is required. So, the growing prevalence of cancer and other infectious diseases such as tuberculosis, meningococcal diseases, etc is one of the major factors expected to drive the growth of the NGS kits market during the forecast period. For instance, according to the data provided by World Health Organization (WHO) in February 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. So, the usage of molecular diagnostics methods in clinical microbiology has increased rapidly in recent years. Molecular diagnostic technologies such as next-generation sequencing (NGS) can detect the presence of nucleic acids and this technology are quick and doesn’t require specimen growth in culture. The researchers can use next-generation sequencing texts to detect different diseases concurrently and directly from a sample. Additionally, replacing the traditional technologies such as microarrays by NGS technology for fast detection will further enhance the demand for NGS kits over the years. For instance, in January 2022, Illumina Inc. and Nashville Biosciences LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), entered a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinical-genomic resource using Illumina's next-generation sequencing (NGS) platforms.

 

Market Segmentation
Global Next Generation Sequencing Kits market can be segmented on the basis of workflow, sequencing type, usage area, application, end users and by region. Based on the workflow, the market is further segmented into library preparation, cluster generation, and sequencing reagents kits. Based on sequencing type, the market can be segmented into WES and WGS, targeted sequencing, long read sequencing, and other sequencing. Based on the usage area, the market can be bifurcated into clinical and research. Based on application, the market can be further grouped into oncology, rare diseases, genetic disorders, reproductive health, and others. Based on end users, the market can be grouped into academic and research institutions, pharmaceutical and biotechnology companies, clinical, diagnostic laboratories, and others. Regionally, in terms of region North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. On the basis of country, the United States dominated the global next generation sequencing kits market on account of the increasing demand for early detection of infectious diseases in the country.

 

Recent Development

  • In January 2021, BGI group received the CE mark approval for the Thalassemia Gene Detection Kit which will be used for the genetic diagnosis of thalassemia and other hemoglobinopathy or for general population carrier screening.
  • In September 2020, Themo Fisher Scientific received the US FDA premarket approval for the Oncomine Dx Target Test as and NGS based companion diagnostic test to identify RET fusion positive, metastatic non-small cell lung cancer patients receiving GAVRETO which is a targeted therapy developed by Blueprint Medicines.


Market Players

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BGI Group., Creative Biogene., Danaher., F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Oxford Nanopore Technologies plc., Pacific Biosciences of California, Inc., PerkinElmer Inc. are some of the leading players operating in the Global Next Generation Sequencing Kits Market.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

By Workflow

By Sequencing Type

By Usage Area

By Application

By End Users

By Region

Regional scope

North America, Europe, Asia Pacific, South America, Middle East & Africa

Country scope

United States, Canada, Mexico, France, Germany, United Kingdom, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Argentina, Colombia, South Africa, Saudi Arabia, UAE

Key companies profiled

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BGI Group., Creative Biogene., Danaher., F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Oxford Nanopore Technologies plc., Pacific Biosciences of California, Inc., PerkinElmer Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global Next Generation Sequencing Kits market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

·         Next Generation Sequencing Kits Market, By Workflow:

o   Library Preparation

o   Cluster Generation

o   Sequencing Reagents Kits

·         Next Generation Sequencing Kits Market, By Sequencing Type:

o   WES and WGS

o   Targeted Sequencing

o   Long Read Sequencing

o   Other Sequencing

·         Next Generation Sequencing Kits Market, By Usage Area:

o   Clinical

o   Research

·         Next Generation Sequencing Kits, By Application:

o   Oncology

o   Rare Diseases

o   Genetic Disorders

o   Reproductive Health

o   Others

·         Next Generation Sequencing Kits, By End User:

o   Academic and Research Institutions

o   Pharmaceutical and Biotechnology Companies

o   Clinical and Diagnostic Laboratories

o   Others

·         Next Generation Sequencing Kits Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  South Korea

§  Australia

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Next Generation Sequencing Kits Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Next Generation Sequencing Kits Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Next Generation Sequencing Kits Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)

5.2.2.     By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)

5.2.3.     By Usage Area (Clinical, Research)

5.2.4.     By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)

5.2.5.     By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)

5.2.6.     By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

5.2.7.     By Company (2022)

5.3.  Market Map

5.3.1 By Workflow

5.3.2 By Sequencing Type

5.3.3 By Usage Area

5.3.4 By Application

5.3.5 By End User

5.3.6 By Region

6.    North America Next Generation Sequencing Kits Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)

6.2.2.     By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)

6.2.3.     By Usage Area (Clinical, Research)

6.2.4.     By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)

6.2.5.     By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)

6.2.6.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Next Generation Sequencing Kits Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Workflow

6.3.1.2.2.             By Sequencing Type

6.3.1.2.3.             By Usage Area

6.3.1.2.4.             By Application

6.3.1.2.5.             By End User

6.3.2.     Canada Next Generation Sequencing Kits Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Workflow

6.3.2.2.2.             By Sequencing Type

6.3.2.2.3.             By Usage Area

6.3.2.2.4.             By Application

6.3.2.2.5.             By End User

6.3.3.     Mexico Next Generation Sequencing Kits Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Workflow

6.3.3.2.2.             By Sequencing Type

6.3.3.2.3.             By Usage Area

6.3.3.2.4.             By Application

6.3.3.2.5.             By End User

7.    Europe Next Generation Sequencing Kits Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)

7.2.2.     By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)

7.2.3.     By Usage Area (Clinical, Research)

7.2.4.     By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)

7.2.5.     By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)

7.2.6.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Next Generation Sequencing Kits Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Workflow

7.3.1.2.2.             By Sequencing Type

7.3.1.2.3.             By Usage Area

7.3.1.2.4.             By Application

7.3.1.2.5.             By End User

7.3.2.     Germany Next Generation Sequencing Kits Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Workflow

7.3.2.2.2.             By Sequencing Type

7.3.2.2.3.             By Usage Area

7.3.2.2.4.             By Application

7.3.2.2.5.             By End User

7.3.3.     United Kingdom Next Generation Sequencing Kits Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Workflow

7.3.3.2.2.             By Sequencing Type

7.3.3.2.3.             By Usage Area

7.3.3.2.4.             By Application

7.3.3.2.5.             By End User

7.3.4.     Italy Next Generation Sequencing Kits Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Workflow

7.3.4.2.2.             By Sequencing Type

7.3.4.2.3.             By Usage Area

7.3.4.2.4.             By Application

7.3.4.2.5.             By End User

7.3.5.     Spain Next Generation Sequencing Kits Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Workflow

7.3.5.2.2.             By Sequencing Type

7.3.5.2.3.             By Usage Area

7.3.5.2.4.             By Application

7.3.5.2.5.             By End User

8.    Asia-Pacific Next Generation Sequencing Kits Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)

8.2.2.     By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)

8.2.3.     By Usage Area (Clinical, Research)

8.2.4.     By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)

8.2.5.     By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)

8.2.6.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Next Generation Sequencing Kits Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Workflow

8.3.1.2.2.             By Sequencing Type

8.3.1.2.3.             By Usage Area

8.3.1.2.4.             By Application

8.3.1.2.5.             By End User

8.3.2.     India Next Generation Sequencing Kits Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Workflow

8.3.2.2.2.             By Sequencing Type

8.3.2.2.3.             By Usage Area

8.3.2.2.4.             By Application

8.3.2.2.5.             By End User

8.3.3.     Japan Next Generation Sequencing Kits Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Workflow

8.3.3.2.2.             By Sequencing Type

8.3.3.2.3.             By Usage Area

8.3.3.2.4.             By Application

8.3.3.2.5.             By End User

8.3.4.     South Korea Next Generation Sequencing Kits Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Workflow

8.3.4.2.2.             By Sequencing Type

8.3.4.2.3.             By Usage Area

8.3.4.2.4.             By Application

8.3.4.2.5.             By End User

8.3.5.     Australia Next Generation Sequencing Kits Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Workflow

8.3.5.2.2.             By Sequencing Type

8.3.5.2.3.             By Usage Area

8.3.5.2.4.             By Application

8.3.5.2.5.             By End User

9.    South America Next Generation Sequencing Kits Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)

9.2.2.     By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)

9.2.3.     By Usage Area (Clinical, Research)

9.2.4.     By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)

9.2.5.     By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)

9.2.6.     By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Next Generation Sequencing Kits Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Workflow

9.3.1.2.2.             By Sequencing Type

9.3.1.2.3.             By Usage Area

9.3.1.2.4.             By Application

9.3.1.2.5.             By End User

9.3.2.     Argentina Next Generation Sequencing Kits Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Workflow

9.3.2.2.2.             By Sequencing Type

9.3.2.2.3.             By Usage Area

9.3.2.2.4.             By Application

9.3.2.2.5.             By End User

9.3.3.     Colombia Next Generation Sequencing Kits Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Workflow

9.3.3.2.2.             By Sequencing Type

9.3.3.2.3.             By Usage Area

9.3.3.2.4.             By Application

9.3.3.2.5.             By End User

10.  Middle East and Africa Next Generation Sequencing Kits Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)

10.2.2.  By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)

10.2.3.  By Usage Area (Clinical, Research)

10.2.4.  By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)

10.2.5.  By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)

10.2.6.  By Country

10.3.              MEA: Country Analysis

10.3.1.  South Africa Next Generation Sequencing Kits Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Workflow

10.3.1.2.2.           By Sequencing Type

10.3.1.2.3.           By Usage Area

10.3.1.2.4.           By Application

10.3.1.2.5.           By End User

10.3.2.  Saudi Arabia Next Generation Sequencing Kits Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Workflow

10.3.2.2.2.           By Sequencing Type

10.3.2.2.3.           By Usage Area

10.3.2.2.4.           By Application

10.3.2.2.5.           By End User

10.3.3.  UAE Next Generation Sequencing Kits Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Workflow

10.3.3.2.2.           By Sequencing Type

10.3.3.2.3.           By Usage Area

10.3.3.2.4.           By Application

10.3.3.2.5.           By End User

11.  Market Dynamics

11.1.              Drivers

11.1.1 Growing advancement in NGS

11.1.2 Growing Demand for Early Detection of Chronic Diseases

11.2.              Challenges

11.2.1 Lack of skilled professionals and infrastructure

11.2.2 Stringent Regulations

12.  Market Trends & Developments

12.1.              Recent Development

12.2.              Mergers & Acquisitions

12.3.              Product Launches

13.  Global Next Generation Sequencing Kits Market: SWOT Analysis

14.  Porter’s Five Forces Analysis

14.1.              Competition in the Industry

14.2.              Potential of New Entrants

14.3.              Power of Suppliers

14.4.              Power of Customers

14.5.              Threat of Substitute Products

15.  Competitive Landscape

15.1.              Business Overview

15.2.              Product Offerings

15.3.              Recent Developments

15.4.              Financials (As Reported)

15.5.              Key Personnel

15.5.1.  Agilent Technologies, Inc.

15.5.2.  Bio-Rad Laboratories, Inc.

15.5.3.  BGI Group.

15.5.4.  Creative Biogene.

15.5.5.  Danaher.

15.5.6.  F. Hoffmann-La Roche Ltd.

15.5.7.  Hologic, Inc.

15.5.8.  Illumina, Inc.

15.5.9.  Oxford Nanopore Technologies plc.

15.5.10.                Pacific Biosciences of California, Inc.

15.5.11.                PerkinElmer Inc.

16. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The rising incidence of cancer and growing applications of NGS technology in infectious diseases research are some of the major factors driving the growth of the Global Next Generation Sequencing Kits market.

down-arrow

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BGI Group., Creative Biogene., Danaher., F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Oxford Nanopore Technologies plc., Pacific Biosciences of California, Inc., and PerkinElmer Inc. are some of the leading players operating in the Global Next Generation Sequencing Kits Market.

down-arrow

Oncology segments are expected to dominate the Global Next Generation Sequencing Kits market during the forecast period owing to an increase in cancer occurrence and advancements in next-generation sequencing (NGS) technology.

down-arrow

North America is expected to hold the largest share in the Global Next Generation Sequencing Kits Market owing to the growing presence of key manufacturers and the active government support.

profile

Sakshi Bajaal

Business Consultant
Press Release

Next Generation Sequencing Kits Market to be Dominated by Oncology Segment through 2028

Feb, 2023

The growing application in clinical diagnosis is expected to drive the growth of Global Next Generation Sequencing Kits Market during the forecast period, 2024-2028.